|
Ryan M. Schwarz is a Managing Director with the Carlyle Group, and is focused on U.S. venture and growth capital opportunities in the healthcare sector. Mr. Schwarz leads the healthcare investing practice in the U.S. Venture & Growth Capital Group with a particular focus on medical devices, medical technology and healthcare information technology. He is based in Washington, DC. Mr. Schwarz previously served as a Vice President in the healthcare group at Robertson Stephens & Co. and as an investment banker at Morgan Stanley & Co. Inc.Mr. Schwarz is on the Board of Directors of AcuFocus, Inc., Endius, Inc., Fairchild Imaging, Inc., Liposonix, Inc., NeoVista, Inc., Primary Health, Inc., Proteus Biomedical, Inc. and Transport Pharmaceuticals, Inc. He was formerly a Director of ConnectiCare Holdings, Inc. (sold to Health Insurance Plan of Greater New York), and Heritage Health Systems, Inc. (sold to Universal American Financial Corp.). | 